Vectorite Biomedical Balance Sheet Health
Financial Health criteria checks 6/6
Vectorite Biomedical has a total shareholder equity of NT$416.9M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$438.2M and NT$21.3M respectively.
Key information
0%
Debt to equity ratio
NT$0
Debt
| Interest coverage ratio | n/a |
| Cash | NT$193.29m |
| Equity | NT$416.92m |
| Total liabilities | NT$21.33m |
| Total assets | NT$438.24m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 4170's short term assets (NT$214.0M) exceed its short term liabilities (NT$12.7M).
Long Term Liabilities: 4170's short term assets (NT$214.0M) exceed its long term liabilities (NT$8.6M).
Debt to Equity History and Analysis
Debt Level: 4170 is debt free.
Reducing Debt: 4170 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 4170 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 4170 has sufficient cash runway for 3 years if free cash flow continues to grow at historical rates of 35.5% each year.